相关实验视频
Updated: May 7, 2026

06:53
Cell Population Analyses During Skin Carcinogenesis
Published on: August 21, 2013
12.4K
治疗先进的基础细胞癌的治疗方法:全面的审查
Magdalena Hoellwerth1, Matthias Brandlmaier1, Peter Koelblinger1
1Department of Dermatology and Allergology, Paracelsus Medical University, Muellner Hauptstraße 48, 5020 Salzburg, Austria.
Cancers
|January 11, 2025
概括
基本细胞癌 (BCC) 是一种常见的皮肤癌,在晚期的治疗中存在挑战. 本综述详细介绍了分子驱动因素,定义了难以治疗的BCC,并比较了刺抑制剂,探索新的治疗策略.
科学领域:
- 皮肤病学 皮肤病学
- 在瘤学瘤学.
- 分子生物学分子生物学
背景情况:
- 基底细胞癌 (BCC) 是最常见的皮肤癌,通常可以通过切除来治愈.
- 当手术或放射治疗不是最佳时,先进或难以治疗的BCC会带来重大治疗挑战.
研究的目的:
- 审查BCC发展背后的分子机制.
- 定义高级/难以治疗的BCC.
- 总结目前和新兴的BCC全身治疗选择.
主要方法:
- 文献综述侧重于BCC的分子病变发生.
- 对已批准的刺抑制剂 (sonidegib和vismodegib) 的关键临床试验数据的分析.
- 探索新的治疗策略,包括新辅助药和组合疗法.
主要成果:
- 像sonidegib和vismodegib这样的刺途径抑制剂 (HHI) 是高级BCC的关键系统治疗方法.
- 关键试验数据的比较突出了已批准的HHIs的疗效和安全性.
- 新兴的新辅助剂和组合方法对难以治疗的BCC有希望.
结论:
- 了解BCC分子病原体对于向治疗至关重要.
- 系统性治疗,特别是HHI,已经改变了先进的BCC管理.
- 未来的方向涉及新的组合和新辅助策略,以改善具有挑战性的BCC病例的结果.
更多相关视频
相关概念视频
Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Skin Cancer
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

